clinical trial · NCT06450106
Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy
Prostate CancerSTM-416p
brief summary
A Study of STM-416p Administered Intraoperatively to Patients Undergoing Radical Prostatectomy
started
May 8, 2025
primary completion
Sep 1, 2026
completion
Dec 1, 2026
last updated
Feb 19, 2026
detailed description
A Phase 1 Dose Escalation Study of STM-416p Administered Intraoperatively to Patients Undergoing Radical Prostatectomy
official title
A Phase 1 Dose Escalation Study of STM-416p Administered Intraoperatively to Patients Undergoing Radical Prostatectomy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol